{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T22:40:44Z","timestamp":1776379244532,"version":"3.51.2"},"reference-count":48,"publisher":"MDPI AG","issue":"17","license":[{"start":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T00:00:00Z","timestamp":1693440000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01NS050452"],"award-info":[{"award-number":["R01NS050452"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Although skeletal muscle (hSKM) has been proven to be actively involved in Amyotrophic Lateral Sclerosis (ALS) neuromuscular junction (NMJ) dysfunction, it is rarely considered as a pharmacological target in preclinical drug discovery. This project investigated how improving ALS hSKM viability and function effects NMJ integrity. Phenotypic ALS NMJ human-on-a-chip models developed from patient-derived induced pluripotent stem cells (iPSCs) were used to study the effect of hSKM-specific creatine treatment on clinically relevant functional ALS NMJ parameters, such as NMJ numbers, fidelity, stability, and fatigue index. Results indicated comparatively enhanced NMJ numbers, fidelity, and stability, as well as reduced fatigue index, across all hSKM-specific creatine-treated systems. Immunocytochemical analysis of the NMJs also revealed improved post-synaptic nicotinic Acetylcholine receptor (AChR) clustering and cluster size in systems supplemented with creatine relative to the un-dosed control. This work strongly suggests hSKM as a therapeutic target in ALS drug discovery. It also demonstrates the need to consider all tissues involved in multi-systemic diseases, such as ALS, in drug discovery efforts. Finally, this work further establishes the BioMEMs NMJ platform as an effective means of performing mutation-specific drug screening, which is a step towards personalized medicine for rare diseases.<\/jats:p>","DOI":"10.3390\/ijms241713519","type":"journal-article","created":{"date-parts":[[2023,8,31]],"date-time":"2023-08-31T09:14:41Z","timestamp":1693473281000},"page":"13519","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["The Effect of Skeletal Muscle-Specific Creatine Treatment on ALS NMJ Integrity and Function"],"prefix":"10.3390","volume":"24","author":[{"given":"Agnes","family":"Badu-Mensah","sequence":"first","affiliation":[{"name":"NanoScience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, FL 32826, USA"},{"name":"Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32816, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiufang","family":"Guo","sequence":"additional","affiliation":[{"name":"NanoScience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, FL 32826, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roxana","family":"Mendez","sequence":"additional","affiliation":[{"name":"NanoScience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, FL 32826, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hemant","family":"Parsaud","sequence":"additional","affiliation":[{"name":"NanoScience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, FL 32826, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James J.","family":"Hickman","sequence":"additional","affiliation":[{"name":"NanoScience Technology Center, University of Central Florida, 12424 Research Parkway, Suite 400, Orlando, FL 32826, USA"},{"name":"Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, Orlando, FL 32816, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,8,31]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fphys.2016.00403","article-title":"Skeletal muscle satellite cells, mitochondria, and micrornas: Their involvement in the pathogenesis of als","volume":"7","author":"Tsitkanou","year":"2016","journal-title":"Front. Physiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.expneurol.2014.05.015","article-title":"Glial cells in amyotrophic lateral sclerosis","volume":"262","author":"Philips","year":"2014","journal-title":"Exp. Neurol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3389\/fnins.2019.01310","article-title":"Als genetics, mechanisms, and therapeutics: Where are we now?","volume":"13","author":"Mejzini","year":"2019","journal-title":"Front. Neurosci."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Pikatza-Menoio, O., Elicegui, A., Bengoetxea, X., Naldaiz-Gastesi, N., L\u00f3pez de Munain, A., Gerenu, G., Gil-Bea, F.J., and Alonso-Mart\u00edn, S. (2021). The skeletal muscle emerges as a new disease target in amyotrophic lateral sclerosis. J. Pers. Med., 11.","DOI":"10.3390\/jpm11070671"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3389\/fnagi.2017.00068","article-title":"Als clinical trials review: 20 years of failure. Are we any closer to registering a new treatment?","volume":"9","author":"Petrov","year":"2017","journal-title":"Front. Aging Neurosci."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Cappello, V., and Francolini, M. (2017). Neuromuscular junction dismantling in amyotrophic lateral sclerosis. Int. J. Mol. Sci., 18.","DOI":"10.3390\/ijms18102092"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.3390\/ijms13011225","article-title":"Disruption of axonal transport in motor neuron diseases","volume":"13","author":"Ikenaka","year":"2012","journal-title":"Int. J. Mol. Sci."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/ana.20379","article-title":"Gene expression profile of spinal motor neurons in sporadic amyotrophic lateral sclerosis","volume":"57","author":"Jiang","year":"2005","journal-title":"Ann. Neurol."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"14302","DOI":"10.1038\/s41598-020-70510-3","article-title":"Skeletal muscle model derived from familial als patient ipscs recapitulates hallmarks of disease progression","volume":"10","author":"Guo","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1038\/s41593-019-0498-9","article-title":"Fus-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis","volume":"22","author":"Picchiarelli","year":"2019","journal-title":"Nat. Neurosci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"121752","DOI":"10.1016\/j.biomaterials.2022.121752","article-title":"Als mutations in both human skeletal muscle and motoneurons differentially affects neuromuscular junction integrity and function","volume":"289","author":"Guo","year":"2022","journal-title":"Biomaterials"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"2000133","DOI":"10.1002\/adtp.202000133","article-title":"A human-based functional nmj system for personalized als modeling and drug testing","volume":"3","author":"Guo","year":"2020","journal-title":"Adv. Ther."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1242\/jcs.190298","article-title":"New links between sod1 and metabolic dysfunction from a yeast model of amyotrophic lateral sclerosis","volume":"129","author":"Bastow","year":"2016","journal-title":"J. Cell Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.pneurobio.2011.06.003","article-title":"Mitochondrial dysfunction in als","volume":"97","author":"Cozzolino","year":"2012","journal-title":"Prog. Neurobiol."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Luo, G., Yi, J., Ma, C., Xiao, Y., Yi, F., Yu, T., and Zhou, J. (2013). Defective mitochondrial dynamics is an early event in skeletal muscle of an amyotrophic lateral sclerosis mouse model. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0082112"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0022-510X(98)00008-2","article-title":"Impairment of mitochondrial function in skeletal muscle of patients with amyotrophic lateral sclerosis","volume":"156","author":"Wiedemann","year":"1998","journal-title":"J. Neurol. Sci."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1080\/14660820310002601","article-title":"Riluzole for amyotrophic lateral sclerosis (als)\/motor neuron disease (mnd)","volume":"4","author":"Miller","year":"2003","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1002\/jnr.24368","article-title":"Enhanced oxidative stress and the treatment by edaravone in mice model of amyotrophic lateral sclerosis","volume":"97","author":"Ohta","year":"2019","journal-title":"J. Neurosci. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.jns.2017.01.021","article-title":"Tempol (4 hydroxy-tempo) inhibits anoxia-induced progression of mitochondrial dysfunction and associated neurobehavioral impairment in neonatal rats","volume":"375","author":"Samaiya","year":"2017","journal-title":"J. Neurol. Sci."},{"key":"ref_20","first-page":"348","article-title":"Evaluation of holistic treatment for als reveals possible mechanism and therapeutic potential","volume":"11","author":"Lavado","year":"2017","journal-title":"Int. J. Pharm. Pharm. Res."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2174\/1389203718666170606105108","article-title":"Creatine supplementation and skeletal muscle metabolism for building muscle mass- review of the potential mechanisms of action","volume":"18","author":"Farshidfar","year":"2017","journal-title":"Curr. Protein Pept. Sci."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Wu, S.-H., Chen, K.-L., Hsu, C., Chen, H.-C., Chen, J.-Y., Yu, S.-Y., and Shiu, Y.-J. (2022). Creatine supplementation for muscle growth: A scoping review of randomized clinical trials from 2012 to 2021. Nutrients, 14.","DOI":"10.3390\/nu14061255"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3389\/fnins.2014.00252","article-title":"Als as a distal axonopathy: Molecular mechanisms affecting neuromuscular junction stability in the presymptomatic stages of the disease","volume":"8","author":"Moloney","year":"2014","journal-title":"Front. Neurosci."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1080\/14660820310017551","article-title":"Dissociation between mechanical and myoelectrical manifestation of muscle fatigue in amyotrophic lateral sclerosis","volume":"5","author":"Sanjak","year":"2004","journal-title":"Amyotroph. Lateral Scler. Other Mot. Neuron Disord."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1212\/01.WNL.0000042781.22278.0A","article-title":"Fatigue and depression are associated with poor quality of life in als","volume":"60","author":"Lou","year":"2003","journal-title":"Neurology"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1136\/jnnp.2008.163246","article-title":"Neurosurgery, psychiatry. Prevalence of fatigue and depression in als patients and change over time","volume":"80","author":"McElhiney","year":"2009","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.jamda.2016.04.019","article-title":"Skeletal muscle regulates metabolism via interorgan crosstalk: Roles in health and disease","volume":"17","author":"Campos","year":"2016","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s10654-017-0318-z","article-title":"Life course body mass index and risk and prognosis of amyotrophic lateral sclerosis: Results from the als registry swabia","volume":"32","author":"Peter","year":"2017","journal-title":"Eur. J. Epidemiol."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.cmet.2008.09.002","article-title":"Skeletal muscle is a primary target of sod1g93a-mediated toxicity","volume":"8","author":"Dobrowolny","year":"2008","journal-title":"Cell Metab."},{"key":"ref_30","doi-asserted-by":"crossref","unstructured":"Quessada, C., Bouscary, A., Ren\u00e9, F., Valle, C., Ferri, A., Ngo, S.T., and Loeffler, J.P. (2021). Skeletal muscle metabolism: Origin or prognostic factor for amyotrophic lateral sclerosis (als) development?. Cells, 10.","DOI":"10.3390\/cells10061449"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"101087","DOI":"10.1016\/j.isci.2020.101087","article-title":"Skeletal-muscle metabolic reprogramming in als-sod1g93a mice predates disease onset and is a promising therapeutic target","volume":"23","author":"Scaricamazza","year":"2020","journal-title":"iScience"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1093\/hmg\/ddq106","article-title":"Skeletal muscle-restricted expression of human sod1 causes motor neuron degeneration in transgenic mice","volume":"19","author":"Wong","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"C1263","DOI":"10.1152\/ajpcell.00162.2007","article-title":"Creatine enhances differentiation of myogenic C2C12 cells by activating both p38 and akt\/pkb pathways","volume":"293","author":"Deldicque","year":"2007","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1152\/japplphysiol.00612.2014","article-title":"Mechanistic investigation of adult myotube response to exercise and drug treatment in vitro using a multiplexed functional assay system","volume":"117","author":"McAleer","year":"2014","journal-title":"J. Appl. Physiol."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S0014-5793(98)01399-4","article-title":"Creatine supplementation improves intracellular Ca2+ handling and survival in mdx skeletal muscle cells","volume":"439","author":"Pulido","year":"1998","journal-title":"FEBS Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1550-2783-7-9","article-title":"Creatine-induced activation of antioxidative defence in myotube cultures revealed by explorative nmr-based metabonomics and proteomics","volume":"7","author":"Young","year":"2010","journal-title":"J. Int. Soc. Sports Nutr."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1152\/japplphysiol.00873.2007","article-title":"Effects of resistance exercise with and without creatine supplementation on gene expression and cell signaling in human skeletal muscle","volume":"104","author":"Deldicque","year":"2008","journal-title":"J. Appl. Physiol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.bbabio.2010.05.005","article-title":"Mitochondria: The calcium connection","volume":"1797","author":"Contreras","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1113\/jphysiol.2008.151027","article-title":"Phosphocreatine as an energy source for actin cytoskeletal rearrangements during myoblast fusion","volume":"586","author":"Steeds","year":"2008","journal-title":"J. Physiol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3389\/fphar.2017.00185","article-title":"Pravastatin chronic treatment sensitizes hypercholesterolemic mice muscle to mitochondrial permeability transition: Protection by creatine or coenzyme q10","volume":"8","author":"Busanello","year":"2017","journal-title":"Front. Pharmacol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/biof.5520080310","article-title":"Some new aspects of creatine kinase (CK): Compartmentation, structure, function and regulation for cellular and mitochondrial bioenergetics and physiology","volume":"8","author":"Wallimann","year":"1998","journal-title":"Biofactors"},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Tokarska-Schlattner, M., Epand, R.F., Meiler, F., Zandomeneghi, G., Neumann, D., Widmer, H.R., Meier, B.H., Epand, R.M., Saks, V., and Wallimann, T. (2012). Phosphocreatine interacts with phospholipids, affects membrane properties and exerts membrane-protective effects. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0043178"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1101\/gad.1525107","article-title":"Pgc-1\u03b1 regulates the neuromuscular junction program and ameliorates duchenne muscular dystrophy","volume":"21","author":"Handschin","year":"2007","journal-title":"Genes Dev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1093\/cvr\/cvn327","article-title":"Tnf-\u03b1 reduces pgc-1 \u03b1 expression through nf-\u03bab and p38 mapk leading to increased glucose oxidation in a human cardiac cell model","volume":"81","author":"Palomer","year":"2009","journal-title":"Cardiovasc. Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1152\/physiolgenomics.00157.2007","article-title":"Global and targeted gene expression and protein content in skeletal muscle of young men following short-term creatine monohydrate supplementation","volume":"32","author":"Safdar","year":"2008","journal-title":"Physiol. Genom."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.biomaterials.2018.02.047","article-title":"Stem cell derived phenotypic human neuromuscular junction model for dose response evaluation of therapeutics","volume":"166","author":"Santhanam","year":"2018","journal-title":"Biomaterials"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1089\/ten.tec.2010.0040","article-title":"Neuromuscular junction formation between human stem cell derived motoneurons and rat skeletal muscle in a defined system","volume":"16","author":"Guo","year":"2010","journal-title":"Tissue Eng. Part. C Methods"},{"key":"ref_48","unstructured":"Hammond, L. (2023, June 01). Measuring Cell Fluorescence Using Imagej. Available online: https:\/\/theolb.readthedocs.io\/en\/latest\/imaging\/measuring-cell-fluorescence-using-imagej.html."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/17\/13519\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T20:43:54Z","timestamp":1760129034000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/24\/17\/13519"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,31]]},"references-count":48,"journal-issue":{"issue":"17","published-online":{"date-parts":[[2023,9]]}},"alternative-id":["ijms241713519"],"URL":"https:\/\/doi.org\/10.3390\/ijms241713519","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,31]]}}}